Clinical Laserthermia Systems AB publishes half-year report January – June 2023
Summary of the interim report (relates to the Group) First semester (01/01/2023–06/30/2023) · Net sales totaled SEK 1,839,000 (SEK 1,089,000). · Profit/loss after financial items totaled SEK -37,980,000 (SEK -31,818,000). · Basic and diluted earnings per share totaled SEK -0.25 (SEK -0.47). · The equity ratio at June 30, 2023, was -31% (0%). The second quarter (04/01/2023 – 06/30/2023) · Net sales totaled SEK 1,252,000 (SEK 381,000). · Profit/loss after financial items totaled SEK -16,516,000 (SEK -17,015,000). · Basic and diluted earnings per share totaled SEK -